Canadian Cannabis Stock News: Worldwide Marijuana (CSE: $WWM) Announces Management & Board Changes

Canadian Cannabis Stock News: Worldwide Marijuana (CSE: $WWM) Announces Management & Board Changes

VANCOUVER, BRITISH COLUMBIA - April 13, 2017 (Investorideas.com Newswire) Worldwide Marijuana Inc. (CSE:WWM)(CSE:WWM.CN) the "Company" or "Worldwide") is pleased to announce the appointment of a new management team to spearhead the recapitalization and reorganization of the Company.

Incoming directors and officer appointments effective April 10, 2017 are as follows:

• President & Chief Executive Officer (CEO) - Mr. Robert van Santen, CPA, CA, CMT
• Chief Financial Officer (CFO) - Ms. Annie Storey, CPA, CA

Mr. Robert Marsh, former President and CEO of the Company, has resigned his executive appointments but will remain as a director to provide guidance and continuity to the new management team. The directors of the Company are therefore Rob van Santen, Annie Storey, and Bob Marsh.

The immediate objective is to bring the Company's required filings up to date under National Instrument 51-102 of the Canadian Securities Administrators, which includes the audited annual financial statements with accompanying MD&A and Officer Certificates as at and for the years ended October 31, 2015 and 2016. After completion of these filings, the Company will re-apply to meet all the initial listing requirements of the Canadian Securities Exchange by way of a new Listing Application as a Life Sciences Issuer.

Mr. van Santen has over 30 years of investment industry and financing experience, providing financial and intellectual capital to both private business and the public markets. He began his career in 1986 as an Investment Advisor with Burns Fry (now BMO Nesbitt Burns), was recognized as "Broker of the Year" in 1994, and left the industry as a Senior VP to establish family-controlled venture capital, merchant, and investment banking operations. Mr. van Santen is currently Managing Director of Agilis Capital Corp., CIO at Westland Capital Advisors S.A., and Chairman and CEO of Valens GroWorks Corp., a publicly-traded cannabis-focused company integrating an end-to-end global "plants to premium products" bioscience platform. Rob holds a Bachelor of Commerce degree in organizational behavior from Concordia University, Chartered Accountant, Chartered Professional Accountant, and Chartered Market Technician's designations, as well as certifications that include the Canadian Securities Institute's CSC (Honours), CPC (Honours), PDO and the OLC.

Ms. Storey brings over 25 years of diverse financial reporting and management experience, including seventeen years in public practice in the areas of audit, accounting, and quality control with national (MNP) and international (KPMG) financial consulting and advisory firms. As a public company audit partner, she navigated complex regulatory environments to meet cross-border reporting requirements. Ms. Storey holds Chartered Accountant and Chartered Professional Accountant designations, has held teaching positions with the BCIT and the CA School of Business, and CFO and director positions with several publicly traded companies. Ms. Storey earned a Bachelor of Business Administration degree from Simon Fraser University with majors in finance and international business, and is a member of the Institute of Chartered Accountants of B.C.'s Practice Review & Licensing Committee, the Canadian Institute of Chartered Accountants' Practitioners' Technical Advisory Committee, and regularly participates on boards of non-profit organizations.

"I welcome this opportunity to join Bob and Annie on the Board, and to apply corporate reorganization experience and connections to assist in the resurrection of Worldwide Marijuana. The rapidly growing medical-marijuana industry offers considerable opportunities for consolidation, with specific knowhow and solid operational experience in short supply." said Rob van Santen, incoming CEO. "With the talent and operational experience available within my growing network, our objective is to bring together a team that can capitalize on the myriad of timely opportunities the end of prohibition offers."

On behalf of the Board of Directors,

WORLDWIDE MARIJUANA INC.

(signed) "Robert van Santen"

Chief Executive Officer

Cautionary statements

This press release contains forward-looking information based on current expectations. Statements about the Company's expectations are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Worldwide Marijuana assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. We seek safe harbor.

Contact Information

Greg Patchell
Telephone: +1.250.860.8634

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Canadian Cannabis Stock News: Aphria (TSX: $APH) (OTCQB: $APHQF) Records fifth consecutive quarter of profitability

 

Increases capacity expectations for Part II, III & IV expansion projects to meet growing demand

LEAMINGTON, ONTARIO - April 13, 2017 (Investorideas.com Newswire) Aphria Inc. ("Aphria" or the "Company") (TSX:APH)(OTCQB:APHQF) today reported its third quarter results, for the three and nine months ended February 28, 2017. All amounts are expressed in Canadian dollars.

Business highlights

• Fifth consecutive quarter of profitability
• Over $3.2 million of year-to-date EBITDA
• Increased our capacity expectations for Part II (to 8,000 kgs), Part III (to 22,000 kgs) & to Part IV (75,000 kgs)
• Invested $1,000,000 in Resolve Digital Health Inc.
• Invested $1,000,000 in Tetra Bio-Pharma Inc., which was subsequently increased to $2,300,000 after exercising warrants in the subsequent events period
• Secured 200 acres of serviced farm land in Leamington, Ontario for $6,240,000 as a secondary site to our existing campus
• Invested an additional $1,300,000 USD in Copperstate Farms Investors, LLC, which was subsequently increased by a further $3,000,000 USD investment in the subsequent events period
• Invested $8,400,000 in Canabo Medical Inc.
• Received Board approval to commence Part IV expansion with a $137,000,000 capital budget
• Committed $2,000,000 in investment to Green Acres Capital Fund, advancing $300,000
• Invested just over $2,000,000 in Kalytera Therapeutics Ltd.
• Raised $53,869,357 in a bought deal financing which closed on February 24, 2017
• Received final approval to list on the Toronto Stock Exchange ("TSX"). Shares commenced trading on the TSX and were delisted from the TSX-Venture Exchange on March 22, 2017

"With five consecutive quarters of profitability and further growth in our production capacity, Aphria continued to build strong, positive momentum in the third quarter," said Vic Neufeld, Chief Executive Officer, Aphria. "Despite unusual weather conditions that temporarily added to our growing costs for the quarter, we continue to report costs per gram that are among the lowest in the industry. At the same time, we are making strategic investments that will increase our supply of high-quality cannabis and position Aphria to drive further growth in our medical-grade cannabis business, meet future demand for recreational cannabis, and drive strong, sustainable shareholder value creation."

Financial highlights

For the fifth consecutive quarter, the Company reported profitability. In the last five quarters, the Company reported income before tax of $3,720, $102,164, $895,269, $945,678 and $4,950,250, respectively. The increased pre-tax profitability is primarily a result of the increase in fair value of long-term investment portfolio.

The Company continued to report strong EBITDA levels, reporting $1,005,073 of EBITDA in the quarter. This is the Company's third consecutive quarter with EBITDA greater than $1 million. Reported EBITDA levels reflect the Company's continued focus on low cost producer status and industry leading patient care service.

Revenue for the three months ended February 28, 2017 was $5,118,516, representing a 2% decrease over the prior quarter's revenue of $5,226,589. The decrease in revenue for the quarter was consistent with expectations and was primarily a result of the $8.50 per gram cap placed on the price of medical cannabis for veterans. The impact of the price cap on revenue was offset by increased revenue per gram for non-veterans, primarly a result of selling less wholesale product and the continued growth of our cannabis oils.

Adjusted gross profit for the third quarter was $3,582,312 with an adjusted gross margin of 70.0%, generated from both retail and wholesale shipments of medical cannabis. The decrease in the adjusted gross margin from the prior quarter is consistent with the reduction in revenues in the quarter.

During the quarter, our "all-in" costs of dried cannabis per gram increased from $1.79 in the prior quarter to $2.23 in the current quarter, representing a $0.44 increase. The increase largely related to abnormal winter weather conditions in Leamington but also included costs related to preparing for our Part II expansion.

This winter the Leamington area experienced unusual conditions related to the amount of sunlight it received. The most common measure of light intensity is referred to as lumens. During the quarter, the Leamington area received approximately 80% of the historical three-year average of lumens for this period. More specifically, the month of January was 67% of the three-year lumen average and the month of February was 76% of the three-year lumen average. This reduced lumen measure directly led to (i) lower yields on individual cannabis plants during the quarter which caused a $0.20 increase in our "all-in" costs of dried cannabis per gram; and, (ii) increased heating and electrical costs, which caused a $0.14 increase in our "all-in" costs of dried cannabis per gram.

The remaining $0.10 per gram related to incremental labour costs as we added greenhouse staff during the quarter so they would be fully trained to work in our Part II expansion, the moment the area is approved by Health Canada. As we move from Health Canada's approval to use our Part II expansion toward the first sale from that area, we will continue to incur incremental labour costs in our vault and packaging staff. These incremental costs will be directly tied to revised head counts as we properly train staff in advance of additional product flow that will result from the increase in our annual harvest from 2,600 kgs to 8,000 kgs.

Net income for the three months ended February 28, 2017 was $4,950,250 or $0.04 per share as opposed to a net income of $3,720 or $0.00 per share in the same quarter in the previous year and an income before tax of $945,678 or $0.01 per share in the previous quarter.

EBITDA for the third quarter was $1,005,516, compared to an EBITDA of $423,350 in the same period of the prior year and EBITDA of $1,198,620 in the previous quarter.

We have A Good Thing Growing.

Read this release in full at http://www.investorideas.com/420cannabisinvestorideas/Companies/APH/news/2017/04131Profitability.asp

About Aphria

Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licenced producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters.

For more information, visit www.Aphria.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of marijuana and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Contact Information

Vic Neufeld
President & CEO
1-844-427-4742

Disclosure: Aphria Inc. (TSX:APH) (OTCQB:APHQF) is a featured company on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

General Assembly Schedules First Hearing on Proposal to Regulate Marijuana for Adult Use; Coalition of Citizens, Community Leaders, and Organizations Mobilizes in Support of Ending Marijuana Prohibition in Illinois

The Coalition for a Safer Illinois will advocate for SB 316 and HB 2353, which will receive a joint hearing from the Senate and House Appropriations committees on Wednesday, April 19, in the Bilandic Building

CHICAGO - April 12, 2017 (Investorideas.com Newswire) Sponsors of a proposal to regulate and tax marijuana for adult use in Illinois announced Wednesday that lawmakers will hold the first hearing on the bill next week in Chicago.

The Senate and House Appropriations committees will hold a joint hearing on SB 316 and HB 2353 on Wednesday, April 19, in the Michael A. Bilandic Building, according to Senate Committee Chairwoman Heather Steans (D-Chicago) and Rep. Kelly Cassidy (D-Chicago).

"Illinois' marijuana policy is like an old car that the General Assembly has kept on the road these past few years by adding a new part and patching up some old ones," Steans said. "The time has come to start discussing our options for replacing it with a newer model - something more modern and cost-effective with improved safety features."

The lawmakers announced the details of the hearing during a news conference in the James R. Thompson Center. The event served as the formal launch of the Coalition for a Safer Illinois, which will mobilize support for ending marijuana prohibition in the state and advocate for SB 316 and HB 2353.

"Marijuana prohibition poses more potential harm to citizens and our community than marijuana itself," said Rev. Alexander Sharp of Chicago, a spokesman for the coalition and executive director of Clergy for a New Drug Policy (CNDP). "It is forcing marijuana into a dangerous underground market where consumers may encounter violence, contaminated products, and other illegal drugs. Ending prohibition and regulating marijuana for adult use would make Illinois safer."

The Coalition for a Safer Illinois is made up of citizens, community leaders, and local and national organizations includes CNDP, the ACLU of Illinois, Doctors for Cannabis Regulation, Law Enforcement Action Partnership, the Marijuana Policy Project (MPP), and the Illinois chapter of the National Organization for the Reform of Marijuana Laws (NORML). More information about the coalition is available at https://www.SaferIllinois.org.

"Most Americans recognize that marijuana is less harmful than alcohol, and a lot of lawmakers are just starting to come to grips with that fact," said MPP Legislative Counsel Chris Lindsey. "Issuing marijuana possession citations to thousands of adults is not really making anyone safer. But what if law enforcement officials used all that time to address serious crimes instead? It could really make a difference."

SB 316 and HB 2353 would make it legal for adults 21 and older to possess, grow, and purchase limited amounts of marijuana. The state would license and regulate businesses to cultivate, process, test, and sell marijuana to adults, and it would create and enforce strict health and safety regulations, such as testing and labeling requirements and restrictions on marketing.

"We have a great opportunity to examine how these laws are working in other states and develop a system that will work best for Illinois," Cassidy said. "There has been a lot of discussion about the tax revenue and other potential economic benefits. We also need to consider the potential public health and safety benefits of removing marijuana from the criminal market and actually controlling production and sales."

The Coalition for a Safer Illinois is a coalition of citizens, community leaders, and local and national organizations that support ending marijuana prohibition in Illinois and replacing it with a system in which marijuana is regulated and taxed similarly to alcohol. For more information, visit https://www.SaferIllinois.org.

Contact

Chris Lindsey
406-540-2323, clindsey@mpp.org

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Cannabis Stock News: Earth Alive (CSE: $EAC) Announces Commercial Launch of Dr. Marijane Biofertilizer for Cannabis Production

MONTREAL, QUEBEC - April 12, 2017 (Investorideas.com Newswire) Earth Alive Clean Technologies Inc. (CSE:EAC)(CSE:EAC.CN) ("Earth Alive" or the "Company"), a leading Canadian Clean-Tech company, developer and manufacturer of state-of-the-art microbial technology-based products for sustainable agriculture and mining, announces the commercial sales launch of Dr. Marijane, the Company's specially formulated cannabis biofertilizer.

Dr. Marijane is a 100% organic root probiotic that has been shown to increase cannabis yields by up to 28%. Scientific testing and validation of its performance began in 2014, and results have been repeatedly confirmed by several licensed commercial producers over the last year. Starting today, Dr. Marijane is available for purchase by growers in Canada and certain regions of the United States.

"Cannabis is moving out of the basement and into the boardroom, and with that move has come increased public scrutiny. In the face of recent product recalls, it has become crucial for licensed producers to cultivate healthy plants without adding more synthetic and potentially toxic chemicals," stated David Gilmour, CEO of Earth Alive. "Dr. Marijane meets the challenge by boosting marijuana yields and producing vigorous plants in a safe and sustainable way."

Michael K. Warren, VP Global Operations, Agricultural Solutions, noted, "There are more than 20,000 Canadians licensed to grow cannabis for personal use under the current medical marijuana rules. Meanwhile, with the Canadian government planning to legalize recreational marijuana by July 2018, licensed growers are undertaking aggressive plans to expand their production capacity. We are also offering the product in a number of states where production is legal for recreational and medicinal purposes" He concluded, "Dr. Marijane is a specialized biofertilizer designed to bring success to cannabis growers, and we look forward to taking a place in this dynamic and expanding sector."

Dr. Marijane is approved for organic production, does not contain genetically modified ingredients or synthetic chemicals and can be used with soil or soilless substrate. It is available in a range of packaging formats suitable for retail and commercial production. For more information and to order, please visit www.doctormarijane.com.

About Earth Alive Clean Technologies:

Earth Alive aims to be a key player in world markets of environmentally sustainable industrial solutions. The company works with the latest innovations in microbial technology to formulate and patent innovative products that can tackle the most difficult industrial challenges, once only reserved to environmentally harmful chemicals and additives. The Company is focused on environmental sustainability in the agriculture industry, and 2) dust control for the mining industry.

For additional company information, please visit: www.earthalivect.com

The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information

Except for statements of historical fact, this news release contains certain forward-looking statements within the meaning of applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" occur. Although Earth Alive believes that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.

For media information and interview requests:

Mr. David Gilmour
514-814-2899
dgilmour@earthalivect.com
www.earthalivect.com

For investor relations:

Mr. Frederick Chabot
438-863-7071
frederick@contactfinancial.com

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Cannabis Funding News: Flowhub Closes Oversubscribed $3.25 Million Series A Offering

DENVER - April 12, 2017 (Investorideas.com Newswire) Flowhub, a next generation seed-to-sale compliance platform for the cannabis industry, is pleased to announce it has closed an oversubscribed $3,250,000 Series A round of equity financing led by Green Lion Partners and Phyto Partners. Since launching in June 2016, Flowhub has processed close to $200 million in purchases across hundreds of the leading dispensary locations in Colorado, Oregon and Alaska.

"We are thankful for the strong support we've received from some of the leading institutional investors in the cannabis space, giving us the resources we need to take Flowhub to the next level," said Mr. Kyle Sherman, Flowhub's Founder and CEO. "We are confident that within the next few months, a significant percentage of all transactions occurring in the regulated cannabis industry will be facilitated by the Flowhub platform."

Flowhub offers platforms for both retail and cultivation that automatically report mandatory compliance data to state regulators via a direct API. The entire ecosystem has been crafted specifically for the regulated cannabis industry. Flowhub's market share has grown over 300% since Q4 2016 and has attracted some of the largest regulated dispensaries in the country as customers.

"Our business has changed for the better since switching to Flowhub several months ago," said Mr. Matthew Aiken, Owner of Sweet Leaf with several stores in multiple states. "I've been in the industry for years and nobody comes close to offering what Flowhub does. We've seen a major productivity increase in our budtenders, managers, and compliance team and we're saving more time and money than I expected. We're excited to expand our business with Flowhub technology powering our infrastructure."

"We have no shortage of deal flow in the cannabis sector. We've looked at hundreds of investment opportunities in the space and have strong relationships with industry leaders in retail and cultivation. It's clear Flowhub has a unique vision for the future of technology solutions in the industry and we couldn't be happier to be a part of this mission," said Mr. Michael Bologna, CEO of Green Lion Partners.

"The technology solution Flowhub provides is critically important to operators, they can't do business without it. This vertical is where we will see billion dollar valuations in the coming years," said Mr. Larry Schnurmacher of Florida-based Phyto Partners. "We believe the Flowhub team will dominate the technology backbone of the cannabis industry and are proud to have Flowhub in our portfolio allowing our investors the opportunity to invest in this emerging industry."

Grow operation and dispensary owners who would like to learn more about Flowhub are encouraged to visit flowhub.co.

About Flowhub

Flowhub has developed the next generation of seed-to-sale software for the regulated cannabis industry. Flowhub enables growers and dispensaries to streamline their supply chain operations and optimize their profit margins. Flowhub was formed in 2015 and is based in Denver, CO. For more information, please visit flowhub.co.

SOURCE Flowhub

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.